SCHEMBL946979

SCHEMBL946979

CC1=NC(c2cccc(Br)c2)(c2ccc3c(c2)OCCO3)N=C1N

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 14/20 0.42
KCNH2 Q12809 1/20 0.40
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
BLM P54132 1/20 0.38
BACE2 Q9Y5Z0 2/20 0.38
CTSD P07339 1/20 0.38
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
APP P05067 4/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932676 0.86 MAPT (0.38) BACE1MAPTLMNAHTTBLM
SCHEMBL947178 0.85 CTSD (0.37) BACE1MAPTLMNAHTTBLM
SCHEMBL945997 0.81 BACE1 (0.66) BACE1KCNH2BACE2CTSD
SCHEMBL932046 0.81 BACE1 (0.60) BACE1KCNH2BACE2CTSDAPP
SCHEMBL933512 0.79 BACE1 (0.63) BACE1KCNH2BACE2CTSDAPP
SCHEMBL932355 0.78 BACE1 (0.59) BACE1KCNH2BACE2CTSDAPP
SCHEMBL932111 0.77 BACE1 (0.47) BACE1KCNH2MAPTBACE2CTSD
SCHEMBL932108 0.77 BACE1 (0.62) BACE1KCNH2BACE2CTSDAPP
SCHEMBL932706 0.77 BACE1 (0.66) BACE1KCNH2BACE2CTSDAPP
SCHEMBL933522 0.76 BACE1 (0.62) BACE1KCNH2BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed